IL64256A - 2,4-diamino-5-(substituted methyl)-pyrimidines,their preparation and pharmaceutical compositions containing them - Google Patents

2,4-diamino-5-(substituted methyl)-pyrimidines,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL64256A
IL64256A IL64256A IL6425681A IL64256A IL 64256 A IL64256 A IL 64256A IL 64256 A IL64256 A IL 64256A IL 6425681 A IL6425681 A IL 6425681A IL 64256 A IL64256 A IL 64256A
Authority
IL
Israel
Prior art keywords
pyrimidines
diamino
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL64256A
Other languages
English (en)
Other versions
IL64256A0 (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Priority to IL7563581A priority Critical patent/IL75635A/xx
Priority to IL7563481A priority patent/IL75634A/xx
Publication of IL64256A0 publication Critical patent/IL64256A0/xx
Priority to IL75635A priority patent/IL75635A0/xx
Priority to IL75634A priority patent/IL75634A0/xx
Publication of IL64256A publication Critical patent/IL64256A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • C07D239/49Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/40Nitrogen atoms attached in position 8
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/64Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with oxygen atoms directly attached in position 8

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL64256A 1980-11-11 1981-11-10 2,4-diamino-5-(substituted methyl)-pyrimidines,their preparation and pharmaceutical compositions containing them IL64256A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IL7563581A IL75635A (en) 1980-11-11 1981-11-10 5-(substituted methyl)-halopyrimidines
IL7563481A IL75634A (en) 1980-11-11 1981-11-10 2,3-disubstituted propanenitrile and cyanopropanoic acid ester derivatives
IL75635A IL75635A0 (en) 1980-11-11 1985-06-26 Substituted pyrimidine derivatives
IL75634A IL75634A0 (en) 1980-11-11 1985-06-26 Substituted acrylonitrile and cyanopropenoate derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8036135 1980-11-11

Publications (2)

Publication Number Publication Date
IL64256A0 IL64256A0 (en) 1982-02-28
IL64256A true IL64256A (en) 1988-01-31

Family

ID=10517217

Family Applications (1)

Application Number Title Priority Date Filing Date
IL64256A IL64256A (en) 1980-11-11 1981-11-10 2,4-diamino-5-(substituted methyl)-pyrimidines,their preparation and pharmaceutical compositions containing them

Country Status (35)

Country Link
US (4) US4438267A (no)
EP (1) EP0051879B1 (no)
JP (1) JPS57114581A (no)
KR (1) KR880001736B1 (no)
AR (1) AR245447A1 (no)
AU (1) AU549449B2 (no)
CA (1) CA1186310A (no)
CS (1) CS273153B2 (no)
CY (1) CY1419A (no)
DD (1) DD201896A5 (no)
DE (1) DE3173752D1 (no)
DK (1) DK172884B1 (no)
EG (1) EG16107A (no)
ES (5) ES8307759A1 (no)
FI (1) FI76333C (no)
GB (1) GB2087881B (no)
GR (1) GR81317B (no)
HK (1) HK23388A (no)
HU (1) HU188762B (no)
IE (1) IE52128B1 (no)
IL (1) IL64256A (no)
IT (1) IT1210589B (no)
MC (1) MC1418A1 (no)
MY (1) MY8600678A (no)
NO (2) NO160137C (no)
NZ (1) NZ198932A (no)
PH (2) PH22654A (no)
PL (4) PL139827B1 (no)
PT (1) PT73960B (no)
RU (1) RU1819264C (no)
SG (1) SG62686G (no)
SU (4) SU1424732A3 (no)
YU (5) YU42444B (no)
ZA (1) ZA817780B (no)
ZM (1) ZM9481A1 (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438267A (en) * 1980-11-11 1984-03-20 Daluge Susan M Monoheteroring compounds and their use
ZA833067B (en) * 1982-05-01 1984-12-24 Wellcome Found Antibacterial compounds
DK190983A (da) * 1982-05-01 1983-11-02 Wellcome Found 2,4-diamino-5-(substituerede)pyrimidiner, fremgangsmaade til deres fremstilling og mellemprodukter derfor
US4590271A (en) * 1982-05-01 1986-05-20 Burroughs Wellcome Co. 2,4-diamino-5-(substituted)pyrimidines, useful as antimicrobials
US4587341A (en) * 1982-05-07 1986-05-06 Burroughs Wellcome Co. 2,4-diamino-5-(1,2,3,4-tetrahydro-(substituted or unsubstituted)-6-quinolylmethyl)pyrimidines, useful as antimicrobials
CA1244028A (en) * 1983-04-14 1988-11-01 Hans Maag Pyrimidine derivatives
GB8603964D0 (en) * 1986-02-18 1986-03-26 Cooper Animal Health Ltd Compositions
GB8603962D0 (en) * 1986-02-18 1986-03-26 Wellcome Found Chemical compositions
LU86703A1 (fr) * 1986-12-08 1988-07-14 Oreal Composition cosmetique photostable contenant un filtre uv-a et un filtre uv-b,son utilisation pour la protection de la peau contre les rayons uv et procede de stabilisation du filtre uv-a par le filtre uv-b
FI895821A0 (fi) * 1988-12-07 1989-12-05 Wellcome Found Farmaceutiskt aktiva cns foereningar.
GB8903978D0 (en) * 1989-02-22 1989-04-05 Coopers Animal Health Chemical compositions
GB9000241D0 (en) * 1990-01-05 1990-03-07 Coopers Animal Health Pharmaceutical use
RU95113597A (ru) * 1992-12-02 1997-06-10 ФМК Корпорейшн (US) Инсектицидная композиция, способы борьбы с насекомыми
US5707996A (en) * 1995-11-06 1998-01-13 Macleod Pharmaceuticals, Inc. Pharmaceutical solution and methods for preparation thereof
WO1997020839A1 (en) * 1995-12-04 1997-06-12 F. Hoffmann-La Roche Ag Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial
WO2002010156A1 (en) * 2000-07-29 2002-02-07 Arpida Ag Benzofuran derivatives and their use as antibacterial agents
DE60216281T2 (de) * 2001-06-29 2007-07-05 Ab Science Die verwendung von tyrosinkinasehemmer zur behandlung von allergischen erkrankungen
PT1401416E (pt) 2001-06-29 2007-02-28 Ab Science Utilização de inibidores de c-kit para tratar doenças inflamatórias intestinais (dii)
EP1401415B1 (en) * 2001-06-29 2006-06-21 AB Science Use of n-phenyl-2-pyrimidine-amine derivatives for treating inflammatory diseases
JP2005500041A (ja) * 2001-06-29 2005-01-06 アブ サイエンス 強力で選択的かつ非毒性のc−kit阻害剤
DE60227701D1 (de) * 2001-09-20 2008-08-28 Ab Science Die verwendung von c-kithemmern zur förderung des haarwuchses
DE60225590T2 (de) * 2001-09-20 2008-09-25 Ab Science C-kithemmer zur behandlung von bakteriellen infektionen
US20040242601A1 (en) * 2001-09-20 2004-12-02 Alain Moussy Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis
EP1651639B1 (en) * 2003-07-11 2010-05-26 Arpida AG, Benzofuran derivatives and their use in the treatment of microbial infections
AU2006215785A1 (en) * 2005-02-18 2006-08-24 Arpida Ag Novel processes for the preparation of a benzofuran
KR101025381B1 (ko) * 2005-09-01 2011-03-28 에프. 호프만-라 로슈 아게 P2x3 및 p2x2/3 조정자로서의 다이아미노피리미딘
US20100029689A1 (en) * 2008-07-02 2010-02-04 Memory Pharmaceuticals Corporation Phosphodiesterase 4 inhibitors
JP5756096B2 (ja) * 2009-06-12 2015-07-29 ソックプラ−シアンセ エ ジェニー エス.ウ.セ. グアニンリボスイッチ結合化合物及び抗生物質としてのその使用
CN102649786B (zh) * 2011-02-28 2014-08-27 郑州福源动物药业有限公司 一种2,4-二氨基-5-(8-二甲氨基-7-甲基-5-喹啉基甲基)-2,4-(1h,3h)嘧啶的制备方法
CN103755684B (zh) * 2014-02-10 2015-09-09 青岛蔚蓝生物股份有限公司 一种巴喹普林的制备方法
US20220332714A1 (en) * 2019-06-06 2022-10-20 Beijing Tide Pharmaceutical Co., Ltd. P2x3 and/or p2x2/3 receptor antagonist, pharmaceutical composition containing same, and use thereof
CN110818694B (zh) * 2019-11-18 2023-04-21 上海医药工业研究院有限公司 艾拉普林中间体及其应用
EP4320104A1 (en) * 2021-04-09 2024-02-14 The Trustees of The University of Pennsylvania Control of protein expression with tmp-protac compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3049544A (en) * 1962-08-14 Method for the preparation of
DE1303727B (de) 1959-09-03 1976-02-05 Ausscheidung aus: 14 45 176 The Wellcome Foundation Ltd., London Alpha-Arylidensubstituierte Propioni-Irile
US3956327A (en) * 1969-03-06 1976-05-11 Burroughs Wellcome Co. Method of preparing 2,4-diamino-5-benzyl pyrimidines
BE792096A (fr) * 1971-12-01 1973-05-30 Hoffmann La Roche Nouvelles benzylpyrimidines
GB1468374A (en) 1974-03-06 1977-03-23 Wellcome Found Process for preparing a pyrimidine derivative
US4039543A (en) 1974-12-24 1977-08-02 Hoffmann-La Roche Inc. Benzylpyrimidines
GB1582245A (en) * 1976-06-09 1981-01-07 Wellcome Found Benzyl cyanoacetal derivatives and their conversion to pyrimidine derivatives
DE2730467A1 (de) * 1977-07-06 1979-01-18 Basf Ag Benzylpyrimidine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4258045A (en) * 1979-11-30 1981-03-24 Merck & Co., Inc. Inhibitor of dihydrofolate reductase
US4438267A (en) * 1980-11-11 1984-03-20 Daluge Susan M Monoheteroring compounds and their use

Also Published As

Publication number Publication date
YU42444B (en) 1988-08-31
JPS57114581A (en) 1982-07-16
GR81317B (no) 1984-12-11
YU266381A (en) 1984-04-30
NO1994029I1 (no) 1994-12-29
ES521202A0 (es) 1984-06-01
ES521201A0 (es) 1984-06-01
US4761475A (en) 1988-08-02
IE52128B1 (en) 1987-06-24
FI76333C (fi) 1988-10-10
YU144288A (en) 1990-04-30
YU198283A (en) 1984-04-30
CS273153B2 (en) 1991-03-12
ZM9481A1 (en) 1983-11-21
ES521203A0 (es) 1984-06-01
PL239280A1 (en) 1983-08-01
HU188762B (en) 1986-05-28
YU198183A (en) 1984-04-30
ES8405380A1 (es) 1984-06-01
NO160137B (no) 1988-12-05
ES8405379A1 (es) 1984-06-01
MC1418A1 (fr) 1982-10-18
NZ198932A (en) 1985-05-31
EP0051879A3 (en) 1982-08-04
PH25053A (en) 1991-01-28
JPH0474351B2 (no) 1992-11-26
ZA817780B (en) 1983-06-29
SG62686G (en) 1987-03-27
PT73960B (en) 1983-11-23
SU1535379A3 (ru) 1990-01-07
ES521204A0 (es) 1984-06-01
PL239278A1 (en) 1983-08-01
DK496681A (da) 1982-05-12
CS825781A2 (en) 1990-07-12
CY1419A (en) 1988-04-22
AR245447A1 (es) 1994-01-31
YU46697B (sh) 1994-04-05
AU549449B2 (en) 1986-01-30
DE3173752D1 (en) 1986-03-20
ES506969A0 (es) 1983-07-01
IT8149676A0 (it) 1981-11-10
DK172884B1 (da) 1999-09-06
KR830007628A (ko) 1983-11-04
GB2087881A (en) 1982-06-03
PL139427B1 (en) 1987-01-31
FI76333B (fi) 1988-06-30
FI813546L (fi) 1982-05-12
IE812631L (en) 1982-05-11
IT1210589B (it) 1989-09-14
ES8405377A1 (es) 1984-06-01
ES8405378A1 (es) 1984-06-01
PL139828B1 (en) 1987-02-28
NO813804L (no) 1982-05-12
EP0051879B1 (en) 1986-02-05
YU43551B (en) 1989-08-31
EP0051879A2 (en) 1982-05-19
DD201896A5 (de) 1983-08-17
AU7733481A (en) 1982-05-20
CA1186310A (en) 1985-04-30
RU1819264C (ru) 1993-05-30
SU1306473A3 (ru) 1987-04-23
KR880001736B1 (ko) 1988-09-10
PL139523B1 (en) 1987-01-31
MY8600678A (en) 1986-12-31
PL239279A1 (en) 1983-08-01
IL64256A0 (en) 1982-02-28
NO160137C (no) 1989-03-15
EG16107A (en) 1987-10-30
US4603136A (en) 1986-07-29
YU198383A (en) 1984-04-30
ES8307759A1 (es) 1983-07-01
HK23388A (en) 1988-04-08
PL233754A1 (en) 1983-08-01
PL139827B1 (en) 1987-02-28
PH22654A (en) 1988-10-28
US4587342A (en) 1986-05-06
SU1318148A3 (ru) 1987-06-15
SU1424732A3 (ru) 1988-09-15
PT73960A (en) 1981-12-01
GB2087881B (en) 1985-05-15
US4438267A (en) 1984-03-20

Similar Documents

Publication Publication Date Title
IL64256A (en) 2,4-diamino-5-(substituted methyl)-pyrimidines,their preparation and pharmaceutical compositions containing them
IL63940A0 (en) Substituted imino-diacids,their preparation and pharmaceutical compositions containing them
IL66099A0 (en) N-aryl-piperazinealkanamides,their preparation and pharmaceutical compositions containing them
IL65814A (en) 3-phenylalkylaminoalkyl-3-benzazepine and 1,3-benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them
IL65257A0 (en) Arylcyclo-butanealkylamine derivatives,their preparation and pharmaceutical compositions containing them
IL64504A (en) Aminoalkoxyphenyl substituted quinazolinones and pyridopyrimidinones,their preparation and pharmaceutical compositions containing them
IL65803A0 (en) Cyclobutene-dione derivatives,their preparation and pharmaceutical compositions containing them
IL64665A (en) 4-amino-6,7-dimethoxy-2-piperazino-quinazoline derivatives,their preparation and pharmaceutical compositions containing them
IL75147A0 (en) Pyrimidine derivatives,their preparation and pharmaceutical compositions containing them
IL60086A0 (en) Pyrimidine compounds,their preparation and pharmaceutical compositions containing them
IL65076A (en) 3,4-dihydro-5h-2,3-benzo-diazepine derivatives,their preparation and pharmaceutical compositions containing them
IL64777A0 (en) 3-aminopropoxyaryl derivatives,their preparation and pharmaceutical compositions containing them
IL66683A0 (en) Benzo-heterocycles,their preparation and pharmaceutical compositions containing them
IL63368A0 (en) 4,5-diaryl-alpha-polyfluoroalkyl-1h-imidazole-2-methanamines,their preparation and pharmaceutical compositions containing them
IL65327A0 (en) Acylquinolinone derivatives,their preparation and pharmaceutical compositions containing them
ZA816844B (en) Substituted iminodiacids,their preparation and pharmaceutical compositions containing them
IL57081A0 (en) Substituted 1,3-diarly-2-imino-imidazolidines and hexahydropyrimidines their preparation and pharmaceutical compositions containing them
IL66238A0 (en) Benzothiazolesulfonamide derivatives,their preparation and pharmaceutical compositions containing them
IL65160A (en) Substituted heteroaromatic guanidine derivatives,their preparation and pharmaceutical compositions containing them
IL63773A0 (en) Penicillanoyloxymethyl penicillanate 1,1,1',1'-tetraoxide,its preparation and pharmaceutical compositions containing it
IL65422A (en) 2-piperazino-pyrimidine derivatives,their preparation and pharmaceutical compositions containing them
IL64563A0 (en) 3,4-bis-substituted 1,2,5-oxidiazole 2-oxides,their preparation and pharmaceutical compositions containing them
IL64252A (en) 3,3-dimethyl-indolin-2-ones,their preparation and pharmaceutical compositions containing them
IL69407A (en) 2(1h)-pyridinones,their preparation and pharmaceutical compositions containing them
DE3366170D1 (en) Pyrimidone compounds, their preparation, and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
EXP Patent expired